Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses

Eleni KontakiLaboratory of Autoimmunity and Inflammation, University of Crete Medical School, and Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece,

Dimitrios T. BoumpasLaboratory of Autoimmunity and Inflammation, University of Crete Medical School, and Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece,

Maria TzardiLaboratory of Cytopathology, University of Crete Medical School, Heraklion, Greece,

Ioannis A. MouzasDivision of Gastroenterology, University of Crete Medical School, Heraklion, Greece, and

Konstantinos A. PapadakisDivision of Gastroenterology, University of Crete Medical School, Heraklion, Greece, and

Panayotis VerginisDivision of Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, GreeceCorrespondence[email protected]

Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date